HomeERIS • NSE
add
Eris Lifesciences Ltd
Previous close
₹1,691.70
Day range
₹1,683.80 - ₹1,725.00
Year range
₹987.10 - ₹1,725.00
Market cap
233.66B INR
Avg Volume
217.64K
P/E ratio
66.47
Dividend yield
0.43%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 7.03B | 28.38% |
Operating expense | 3.57B | 13.00% |
Net income | 938.40M | 32.24% |
Net profit margin | 13.36 | 3.01% |
Earnings per share | 6.89 | 32.25% |
EBITDA | 2.54B | 83.11% |
Effective tax rate | 20.58% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.28B | -82.98% |
Total assets | 70.33B | -0.22% |
Total liabilities | 37.61B | -1.71% |
Total equity | 32.72B | — |
Shares outstanding | 136.00M | — |
Price to book | 8.06 | — |
Return on assets | — | — |
Return on capital | 7.51% | — |
Cash Flow
Net change in cash
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 938.40M | 32.24% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2007
Website
Employees
3,620